131 related articles for article (PubMed ID: 20149858)
1. MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion.
Han YH; Park WH
Toxicol In Vitro; 2010 Jun; 24(4):1237-42. PubMed ID: 20149858
[TBL] [Abstract][Full Text] [Related]
2. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
Han YH; Park WH
Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
[TBL] [Abstract][Full Text] [Related]
3. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316
[TBL] [Abstract][Full Text] [Related]
4. MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level.
Han YH; Park WH
Hum Exp Toxicol; 2010 Jul; 29(7):607-14. PubMed ID: 20053704
[TBL] [Abstract][Full Text] [Related]
5. The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH.
Han YH; Moon HJ; You BR; Park WH
Oncol Rep; 2009 Jul; 22(1):215-21. PubMed ID: 19513526
[TBL] [Abstract][Full Text] [Related]
6. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
Han YH; Moon HJ; You BR; Park WH
Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
Park WH
Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
[TBL] [Abstract][Full Text] [Related]
8. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death.
Han YH; Park WH
Chem Biol Interact; 2010 Mar; 184(3):319-27. PubMed ID: 20100472
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitor MG132 reduces growth of As4.1 juxtaglomerular cells via caspase-independent apoptosis.
Han YH; Park WH
Arch Toxicol; 2010 Sep; 84(9):689-98. PubMed ID: 20449726
[TBL] [Abstract][Full Text] [Related]
10. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
You BR; Park WH
Toxicol In Vitro; 2010 Aug; 24(5):1356-62. PubMed ID: 20417267
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion.
Han YH; Yang YM; Kim SZ; Park WH
Anticancer Res; 2010 Jun; 30(6):2107-12. PubMed ID: 20651358
[TBL] [Abstract][Full Text] [Related]
12. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
13. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
Han YH; Kim SH; Kim SZ; Park WH
Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
[TBL] [Abstract][Full Text] [Related]
14. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
[TBL] [Abstract][Full Text] [Related]
15. The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132.
You BR; Park WH
Oncol Rep; 2011 Mar; 25(3):871-7. PubMed ID: 21186403
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
Han YH; Kim SZ; Kim SH; Park WH
Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
[TBL] [Abstract][Full Text] [Related]
17. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.
Han YH; Park WH
Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death.
Han YH; Kim SZ; Kim SH; Park WH
Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736
[TBL] [Abstract][Full Text] [Related]
19. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Park WH
Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
[TBL] [Abstract][Full Text] [Related]
20. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
